| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1493.12 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1249.51 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1152.88 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 1544.21 | 97 |
| GSM780720 | Untreated after 4 days (C2_2) | 1236.55 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1214.63 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1554.87 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1481.65 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1934.46 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1579 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1604.52 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1940.2 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1308.31 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1348.1 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1335.04 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1511.89 | 97 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1651.58 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1444.83 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1930.12 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2047.73 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1669.86 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1980.91 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1789.36 | 98 |